Development Level

Tbio 5 | 11,445
Tclin 4 | 613
Tchem 3 | 1,598

IMPC Phenotype

decreased total body fat amoun... 4 | 207
preweaning lethality, complete... 3 | 979
embryonic lethality prior to t... 2 | 278
preweaning lethality, incomple... 2 | 499
thrombocytopenia 2 | 56
abnormal behavioral response t... 1 | 66
cardiovascular system phenotyp... 1 | 36
decreased KLRG1+ CD4 alpha bet... 1 | 5
decreased anxiety-related resp... 1 | 12
decreased lean body mass 1 | 135
decreased lymphocyte cell numb... 1 | 83
decreased mean corpuscular vol... 1 | 79
decreased prepulse inhibition 1 | 82
embryonic lethality prior to o... 1 | 239
increased anti-nuclear antigen... 1 | 19
increased circulating HDL chol... 1 | 80
increased circulating alkaline... 1 | 122
increased circulating choleste... 1 | 66
increased circulating phosphat... 1 | 26
increased lean body mass 1 | 172
increased mean corpuscular hem... 1 | 96
increased monocyte cell number 1 | 63
increased neutrophil cell numb... 1 | 46
increased startle reflex 1 | 112
increased total body fat amoun... 1 | 134
prenatal lethality prior to he... 1 | 87

Disease

Carcinoma 8 | 11,493
Schizophrenia 7 | 1,160
osteosarcoma 7 | 7,950
Bipolar Disorder 5 | 666
Major Depressive Disorder 5 | 301
glioblastoma 5 | 5,792
Amphetamine-Related Disorders 4 | 74
Attention deficit hyperactivity disorder 4 | 278
Cancer 4 | 2,499
Cocaine Dependence 4 | 51
Depressive disorder 4 | 409
Hypertension 4 | 396
Mental Depression 4 | 333
Mood Disorders 4 | 184
Seizures 4 | 596
Unipolar Depression 4 | 250
atypical teratoid / rhabdoid tumor 4 | 5,112
invasive ductal carcinoma 4 | 2,951
lung carcinoma 4 | 2,843
malignant mesothelioma 4 | 3,232
medulloblastoma, large-cell 4 | 6,241
psoriasis 4 | 6,694
Alcohol dependence 3 | 107
Alcoholic Intoxication, Chronic 3 | 289
Autistic Disorder 3 | 364
Cocaine abuse 3 | 19
Cocaine-Related Disorders 3 | 92
Hyperactive behavior 3 | 91
Migraine 3 | 83
Opiate dependence 3 | 29
Substance abuse 3 | 59
ductal carcinoma in situ 3 | 1,745
lung cancer 3 | 4,740
non-small cell lung cancer 3 | 2,890
Acromegaly 2 | 51
Adenoma 2 | 167
Alcohol abuse 2 | 50
Basal Ganglia Diseases 2 | 14
Chronic schizophrenia 2 | 16
Cognition Disorders 2 | 32
Delirium 2 | 10
Disruptive, Impulse Control, and Conduct Disorders 2 | 3
Dyskinesia, Drug-Induced 2 | 15
Gilles de la Tourette syndrome 2 | 47
Heart disease 2 | 306
Hyperalgesia 2 | 83
Hyperkinesis 2 | 32
Hypertensive disease 2 | 292
Hypotension 2 | 82
Kidney cancer 2 | 2,613
Kidney disease 2 | 430
Liver Cirrhosis, Experimental 2 | 769
Movement Disorders 2 | 55
Muscle hypotonia 2 | 571
Myoclonus 2 | 74
Nausea and vomiting 2 | 97
Nonpsychotic Anxiety 2 | 2
Obesity 2 | 678
Pain 2 | 103
Pain agnosia 2 | 104
Parkinson's disease 2 | 392
Pathological gambling 2 | 15
Phaeochromocytoma 2 | 20
Prolonged-Severe Nausea and Vomiting 2 | 2
Recurrent depression 2 | 9
adrenocortical carcinoma 2 | 1,428
astrocytic glioma 2 | 2,597
ependymoma 2 | 4,679
group 3 medulloblastoma 2 | 4,104
obsessive-compulsive disorder 2 | 61
pediatric high grade glioma 2 | 1,064
pituitary cancer 2 | 1,972
tuberculosis 2 | 2,010
Alexithymia 1 | 16
Allergic conjunctivitis 1 | 22
Anxiety disorder 1 | 23
Autistic behavior 1 | 20
Axonal degeneration 1 | 7
Cervical Dystonia 1 | 26
Chronic thromboembolic pulmonary hypertension 1 | 4
Cluster headache syndrome 1 | 8
Complex regional pain syndrome 1 | 12
Goiter 1 | 38
Hyperprolactinemia 1 | 27
Hyperthyroidism 1 | 53
Hypoactive sexual desire disorder 1 | 8
Memory Disorders 1 | 40
Migraine Prevention 1 | 23
Multiple endocrine neoplasia type 2A 1 | 20
Multiple endocrine neoplasia type 2B 1 | 17
Myopathies, Structural, Congenital 1 | 15
Onion bulb formation 1 | 19
Osteosclerosis 1 | 31
Personality disorder 1 | 25
Segmental demyelination/remyelination 1 | 8
Spasmodic torticollis 1 | 17
Thyroid adenoma 1 | 10
Thyroiditis 1 | 29
Torticollis 1 | 18
Treatment-resistant schizophrenia 1 | 6

Tissue

Endocrine System 12 | 18,159
Cardiovascular System 11 | 15,192
Digestive Tract 11 | 17,369
Liver and Pancreas 11 | 16,750
Male tissues 11 | 17,142
Nervous System 11 | 16,725
Respiratory system 11 | 16,393
Skin and soft tissues 11 | 17,230
Blood and immune system 10 | 16,909
Female tissues 10 | 17,400
Urinary Tract 10 | 16,678

Target Family

Non-IDG 7 | 12,091
GPCR 4 | 408
Kinase 1 | 634

GO Process

G-protein coupled receptor int... 12 | 12
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
5-hydroxytryptamine receptor 2B HTR2B Tclin GPCR -2.66641 486.3 265
General transcription factor IIH subunit 2 GTF2H2 Tbio Non-IDG -1.32757 20.2 148
ADM ADM Tbio Non-IDG -3.27504 1889.0 381
D(3) dopamine receptor DRD3 Tclin GPCR -2.51699 312.3 189
Dynamin-1 DNM1 Tbio Non-IDG -2.67692 450.0 464
G protein-coupled receptor kinase 4 GRK4 Tchem Kinase -1.71379 54.8 171
5-hydroxytryptamine receptor 1B HTR1B Tclin GPCR -3.03042 1068.4 211
Calcitonin gene-related peptide 1 CALCA Tchem Non-IDG -3.70355 8831.3 1309
D(2) dopamine receptor DRD2 Tclin GPCR -3.28700 1882.2 264
Beta-arrestin-1 ARRB1 Tbio Non-IDG -2.63877 418.5 490